1 Min Read
Nov 3 (Reuters) - Horizon Pharma Plc
* Horizon pharma plc announces availability of ravicti (glycerol phenylbutyrate) oral liquid in canada Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.